GENESIS Pharma

GENESIS Pharma began its pharmaceutical biotechnology operations in 1997. The company's goal is to combine the rapid advancements of science with successful innovative enterprises, paving the way for a new market. To this end, GENESIS Pharma has made relentless efforts to become the first pharmaceutical company in Greece specializing in the promotion, sales, and distribution of biopharmaceutical products. It is also currently the company with the largest turnover among Greek companies focusing on innovative branded medicines. The company’s portfolio mainly includes innovative drugs in therapeutic areas such as oncology, hematology, central nervous system, inflammation and immunology, gastroenterology, and nephrology, which are the result of collaborations with large multinational pharmaceutical companies. Among its partners are two of the largest companies by market capitalization, Biogen and Celgene, both of which focus on the research and development of novel pharmaceutical products.